Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Envista Holdings CorpNVST · Entity 4007 | Director | May 19, 2026 | May 21, 2026 |
| ICU MEDICAL INC/DEICUI · Entity 2385 | Director · Chairman and CEO | March 15, 2026 | March 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Envista Holdings Corp
Report date May 19, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,945 |
Reported balance
After 2026-05-19 transaction · row 1
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 9,330 · Balance 52,945 F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.
ICU MEDICAL INC/DE
Report date March 15, 2026 · Filed March 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 134,106 |
Reported balance
After 2026-03-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-15 · Exercise / conversion · Acquired 17,100 · Balance 134,106 F1: These Securities are Performance-based Restricted Stock Units (PRSU). F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. |
| Common StockSEC Table I · non-derivative | Direct | 124,654 |
Reported balance
After 2026-03-15 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-03-15 · Tax withholding · Disposed 9,452 · Balance 124,654 F1: These Securities are Performance-based Restricted Stock Units (PRSU). |
| Common StockSEC Table I · non-derivative | Direct | 129,526 |
Reported balance
After 2026-03-15 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-03-15 · Exercise / conversion · Acquired 4,872 · Balance 129,526 F3: These securities are Restricted Stock Units. |
| Common StockSEC Table I · non-derivative | Direct | 126,833 |
Reported balance
After 2026-03-15 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-03-15 · Tax withholding · Disposed 2,693 · Balance 126,833 F3: These securities are Restricted Stock Units. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-03-15 | Direct | 0 |
Reported balance
After 2026-03-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-15 · Exercise / conversion · Disposed 4,872 · Balance 0 F3: These securities are Restricted Stock Units. F4: There is neither a purchase price nor an exercise price for the Restricted Stock Units. |
| Performance SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-03-15 | Direct | 0 |
Reported balance
After 2026-03-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-03-15 · Exercise / conversion · Disposed 17,100 · Balance 0 F1: These Securities are Performance-based Restricted Stock Units (PRSU). F5: There is neither a purchase price nor an exercise price for the PRSUs. F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. |
| Common StockSEC Table I · non-derivative | Indirectby Trust | 152,339 |
Reported balance
Holding disclosure · report date 2026-03-15 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 152,339 |
Filing footnotes · ownership attribution and instrument terms
F1: These Securities are Performance-based Restricted Stock Units (PRSU).
F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.
F3: These securities are Restricted Stock Units.
F4: There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F5: There is neither a purchase price nor an exercise price for the PRSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 06, 2020 Filed Nov 10, 2020 22:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,500 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-20-000010 · edgardoc.xml · derivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436,366 Underlying: Common Stock · 11,500 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F4 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of the exercise price for 30 consecutive trading days. Read SEC document |
| November 06, 2020 Filed Nov 10, 2020 22:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 11,500 | $195.00 | $2,242,500.00 |
DisclosureSEC source: 0001410442-20-000010 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,241 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F3 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| November 06, 2020 Filed Nov 10, 2020 22:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 11,500 | $58.79 | $676,085.00 |
DisclosureSEC source: 0001410442-20-000010 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. Read SEC document |
| October 30, 2020 Filed Feb 3, 2021 23:17 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GiftNon-Qualified Stock Option (right to buy) · Derivative | 66,000 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-21-000004 · edgardoc.xml · derivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 66,000 Underlying: Common Stock · 66,000 shares Expires 2024-02-24 F1 · ownership.nature: This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| October 30, 2020 Filed Feb 3, 2021 23:17 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GiftNon-Qualified Stock Option (right to buy) · Derivative | 66,000 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-21-000004 · edgardoc.xml · derivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 381,866 Underlying: Common Stock · 66,000 shares Expires 2024-02-24 F1 · kind: This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:04 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,500 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-20-000008 · edgardoc.xml · derivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,866 Underlying: Common Stock · 11,500 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F4 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of the exercise price for 30 consecutive trading days. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:04 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 11,500 | $195.00 | $2,242,500.00 |
DisclosureSEC source: 0001410442-20-000008 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,241 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F3 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:04 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 11,500 | $58.79 | $676,085.00 |
DisclosureSEC source: 0001410442-20-000008 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. Read SEC document |
| September 15, 2020 Filed Feb 3, 2021 23:17 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GiftCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000004 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 60,000 F1 · ownership.nature: This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 15, 2020 Filed Feb 3, 2021 23:17 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GiftCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000004 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,241 F1 · kind: This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 20:45 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,500 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-20-000007 · edgardoc.xml · derivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,366 Underlying: Common Stock · 11,500 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F7 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of the exercise price for 30 consecutive trading days. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 20:45 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 658 | $199.93 | $131,553.15 |
DisclosureSEC source: 0001410442-20-000007 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,181 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.68 to $200.04, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 20:45 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 500 | $198.60 | $99,300.00 |
DisclosureSEC source: 0001410442-20-000007 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,839 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F5 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 20:45 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 1,886 | $197.76 | $372,966.50 |
DisclosureSEC source: 0001410442-20-000007 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,339 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.49 to $198.35, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 20:45 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 8,456 | $196.74 | $1,663,667.26 |
DisclosureSEC source: 0001410442-20-000007 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,225 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.44 to $197.37, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 20:45 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 11,500 | $58.79 | $676,085.00 |
DisclosureSEC source: 0001410442-20-000007 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 21:27 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,500 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-20-000006 · edgardoc.xml · derivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,866 Underlying: Common Stock · 11,500 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F4 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of the exercise price for 30 consecutive trading days. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 21:27 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 11,500 | $195.00 | $2,242,500.00 |
DisclosureSEC source: 0001410442-20-000006 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,181 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F3 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 21:27 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 11,500 | $58.79 | $676,085.00 |
DisclosureSEC source: 0001410442-20-000006 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. Read SEC document |
| June 02, 2020 Filed Jun 3, 2020 20:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GiftCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000005 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,181 F1 · price: This was a bona fide gift with no payment in consideration Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,768 | $202.52 | $560,572.32 |
DisclosureSEC source: 0001410442-20-000005 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,211 F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $202.50 to $202.73, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 12,232 | $204.18 | $2,497,479.61 |
DisclosureSEC source: 0001410442-20-000005 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,979 F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $204.00 to $204.25, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 27, 2020 Filed May 29, 2020 20:22 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantRestricted Stock Unit · Derivative | 8,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-001373 · form4-05292020_010540.xml · derivative · entry 1 Jain Vivek · CIK 0001410442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,230 Underlying: Common Stock · 8,230 shares Expires 2030-05-26 F1 · derivative.exercise_price: Restricted stock units are payable in shares of common stock on a one-to-one basis. F2 · derivative.exercise_date: The restricted stock units granted will vest on the date of the Issuer's 2021 annual meeting of stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the issuer. Read SEC document |
| May 21, 2020 Filed Jun 3, 2020 20:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GiftCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000005 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,211 F1 · price: This was a bona fide gift with no payment in consideration Read SEC document |
| April 07, 2020 Filed Apr 10, 2020 00:15 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 970 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-20-000009 · wf-form4_158647770201496.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 970 F1 · shares: Award of restricted stock units under the Envista Holdings Corporation 2019 Omnibus Incentive Plan, which will vest on the earlier to occur of the first anniversary of the date of grant or the date of the Issuer's 2020 annual meeting of stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 15:31 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,933 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000004 · edgardoc.xml · derivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60 Underlying: Common Stock · 1,933 shares Expires 2020-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 15:31 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000004 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,241 Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 15:31 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,933 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000004 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 19:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000003 · edgardoc.xml · derivative · entry 7 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,888 Underlying: Common Stock · 1,443 shares Expires 2022-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: These securities are Restricted Stock Units. F1 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F2 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 19:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000003 · edgardoc.xml · derivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,681 Underlying: Common Stock · 2,681 shares Expires 2021-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: These securities are Restricted Stock Units. F1 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F2 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 19:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 5,317 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000003 · edgardoc.xml · derivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,317 Underlying: Common Stock · 5,317 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F2 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 19:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 759 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000003 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,357 Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 19:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000003 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 19:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000003 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,673 Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 19:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000003 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 18:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 5,978 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000002 · edgardoc.xml · derivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,934 shares Expires 2019-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F3 · shares: Each PRSU reflects the contingent right to receive a variable number of shares of common stock based on achieving performance goals. At the determination date, based on certification of the achievement of the performance criteria, the reporting person earned 300% of the target award amount. F4 · derivative.exercise_date: These PRSUs were granted on March 27, 2017. The vesting for this performance-based restricted stock unit ("PRSU") award was dependent upon the achievement of a minimum Cumulative Adjusted EBITDA over the Fiscal Years 2017-2019. The reporting person was able to earn PRSUs ranging from 100% to 300% of the target award amount. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 18:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 9,476 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000002 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,403 Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 18:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 17,934 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000002 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2019 Filed May 28, 2019 22:32 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GiftCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-19-000008 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,945 F1 · price: Shares transferred as a bona fide gift without any consideration. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 17:41 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,993 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-19-000006 · edgardoc.xml · derivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,993 Underlying: Common Stock · 1,993 shares Expires 2020-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 17:41 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,993 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-19-000006 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 17:41 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 989 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-19-000006 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,002 Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 18:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 4,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-19-000004 · edgardoc.xml · derivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,331 Underlying: Common Stock · 4,331 shares Expires 2022-03-06 F5 · security: These securities are Restricted Stock Units. F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F7 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 18:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-19-000004 · edgardoc.xml · derivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,362 Underlying: Common Stock · 2,681 shares Expires 2021-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: These securities are Restricted Stock Units. F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F7 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 18:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 11,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-19-000004 · edgardoc.xml · derivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,828 shares Expires 2019-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F3 · shares: Each PRSU reflects the contingent right to receive a variable number of shares of common stock based on achieving performance goals. At the determination date, based on certification of the achievement of the performance criteria, the reporting person earned 300% of the target award amount. F4 · derivative.exercise_date: These PRSUs were granted on February 5, 2016. The vesting for these PRSUs is dependent upon the achievement of performance criteria related to the Company's fiscal year 2018 Adjusted EBITDA per share CAGR in comparison to the fiscal year 2015 Adjusted EBITDA per weighted average basic share. The reporting person may potentially earn 100% to 300% of the target award amount originally reported on the date of grant. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 18:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 18,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-19-000004 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,991 Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 18:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 36,509 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-19-000004 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,093 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 01:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 3,759 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-19-000002 · edgardoc.xml · derivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,759 shares Expires 2019-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 01:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-19-000002 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 01:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,318 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-19-000002 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,825 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.